IONS
USDIonis Pharmaceuticals Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$73.790
Максимум
$75.000
Минимум
$72.360
Объем
0.79M
Фундаментальные показатели компании
Рыночная капитализация
11.9B
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
2.47M
Биржа
NMS
Валюта
USD
52-недельный диапазон
Связанные новости
HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $110
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Ionis Pharmaceuticals with a Buy and raises the price target from $100 to $110.
Piper Sandler Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $77
Piper Sandler analyst Allison Bratzel maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $70 to $77.
TD Cowen Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $99
TD Cowen analyst Yaron Werber maintains Ionis Pharmaceuticals with a Buy and raises the price target from $59 to $99.
Morgan Stanley Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $94
Morgan Stanley analyst Michael Ulz maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $90 to $94.
HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $100
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Ionis Pharmaceuticals with a Buy and raises the price target from $95 to $100.
Barclays Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $95
Barclays analyst Gena Wang maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $80 to $95.
RBC Capital Maintains Outperform on Ionis Pharmaceuticals, Raises Price Target to $82
RBC Capital analyst Luca Issi maintains Ionis Pharmaceuticals with a Outperform and raises the price target from $80 to $82.
Связанные акции
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.